PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer | Synapse
August 26, 2015Open Access
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
Key Points
Key points are not available for this paper at this time.
Abstract
This study is registered with ClinicalTrials.gov identifier NCT02215265 .